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Effects of continuous positive airway pressure
(CPAP) sleep apnea treatment on mild cognitive
impairment (MCI), a precursor state to
Alzheimer’s disease
Olivia Taylor, Cynthia Cheng, MD, PhD*

Introduction
• Current estimates report the prevalence of obstructive sleep apnea (OSA) in the
United States to be 7-9%of the population, thus affecting about 26 million people1,
many who are unaware of their condition

Introduction
• My role in this multi-site project was to screen potential
patients from Jefferson’s sleep clinic for eligibility for study
enrollment.
• Some positive preliminary data - CPAP therapy does seem
to have a beneﬁcial effect as hypothesized on
neuropsychiatric testing, indicating a possible beneﬁt in
slowing the progression of MCI
• COVID delays led to my being less needed on this project in
year 2
• Currently I am playing a key role in a related project examining
the effect of CPAP compliance on cardiovascular risk and
cardiovascular risk factors in OSA patients.
• This is what I will be discussing for the rest of today

• OSA can have many, varied detrimental effects on the cardiovascular system
• I am speciﬁcally focusing on heart rate as a measure of sympathetic nervous system
activation.

Objectives
& Hypothesis
• Research Question
– What is the observed difference in heart rate before and
after initiating CPAP therapy in moderate-severe OSA (AHI
>= 15) patients who are compliant and noncompliant with
CPAP?

• Hypothesis
– Compliance with CPAP therapy (>= 4 hrs of usage/night for
70% of nights/month) leads to a decrease in average
annual heart rate measurements compared to
noncompliant/non CPAP users.

Approach & Results
• Retrospective/prospective cohort study
• Patients with moderate-severe OSA (identiﬁed from
Jefferson Sleep Medicine center) - 2000+ patients
• Intervention was CPAP therapy, separated into
compliant, noncompliant, and non-CPAP control
patients
• EPIC chart reviews, smart card (from CPAP machine)
compliance data analyzed
• Many markers of cardiovascular health are being
recorded - BP, HR, CVD events, lipids, diabetes, and
more

Approach & Results
• Analysis
–

A 10 patient preliminary data analysis was completed using SAS 9.4

Findings
HR change in the CPAP
compliant group was
1.3 + 7.5 (decrease

of 1.3, n=5)
Compared to the
control group (no
CPAP), 0.5 + 2.8
(decrease of 0.5,
n=3)
The p value was not
signiﬁcant, likely due to
the small sample size as
well as the small
difference in heart rate
between the groups.

Conclusions
• Our ﬁndings are still interesting even though the sample
size is so small
• The work that has been done for the past several months
was mostly setting up the database and protocol so that
future students can collect the sample size needed to
follow out the trends
• Excited that the preliminary heart rate ﬁnding is in the
expected direction, demonstrating more of a heart rate
drop for the CPAP group compared to control
• This is positive because lower heart rate is better for CV
risk

Future Directions
• Now that the protocol, variables, and database are
all set, future students can help reach the goal of
2000+ patients included in the study
• More patients and a longer study period (more data
points per patient) will strengthen the study power
• The preliminary data analysis showed trends in the
direction towards improving heart rate, which is a
predictor of CV risk, which is encouraging (although
this was not signiﬁcant)
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